Fibronectin in Basal Cell Epithelioma: Sources and Significance  by Grimwood, Ronald E. et al.
0022-202X/84 /8202-0145$02.00/ 0 
THE J OU HN i\L OF I NVESTI GATIV E D EHMATOLOC:Y, 82:14 5- 149, 1984 
Copyright © 1984 by The Williams & Wilkins Co. 
Vol. 82. No. :1 
Printed in U.S.A . 
Fibronectin in Basal Cell Epithelioma: Sources and Significance 
RONALD E. GRIMWOOD , M.D. , J. C LARK H UFF, M .D ., JOHN W. HARBELL, PH.D., AND 
RICHARD A. F. C LARK, M.D . 
Department of Dermatology. University of Colorado (REG. J CH, RAFC), Department of Clinical lnvesligation, Fitzsimons Army Medical Center 
(REG, JWH). and Departmen t of Medicine, National J ewish Hospital (RAFC). Denver, Colorado, U.S.A. 
Nodular basal cell epitheliomas (BCE) contain fibro-
nectin both within tumor nodules and at the nodule-
stroma interface (basement membrane zone). Fibronec-
tin within or at the periphery of tumor nodules could be 
derived from the tumor cells, from entrapped stroma, or 
from plasma. The present study was designed to eluci-
date the source(s) of fibronectin within BCE nodules. 
If stromal entrapment occurred to any great extent, 
von Willebrand factor VIII:Ag-stained blood vessels 
within tumor nodules should be evident by immuno-
fluorescence techniques. Likewise, if plasma proteins 
were deposited in BCE, the tumor nodules should stain 
with fluorescein-conjugated antifibrinogen antibodies. 
Therefore, 6 basal cell epitheliomas were double labeled 
w ith rhodamine-conjugated antihuman fibronectin and 
fluorescein-con jugated antihuman factor VIII:Ag or 
fluorescein- labeled antihuman fibrinogen. 
Fibronectin was present in a linear disposition along 
the margin of tumor lobules and as a fine filamentous 
deposit in the central portions of tumor tissue. There 
was no evidence of fibrinogen or factor VIII:Ag in any 
of the tumor lobules. Factor VIII:Ag was present in a 
granular pattern within blood vessel walls that coursed 
between tumor nests. An indirect immunoperoxidase 
technique using rabbit antihuman fibronectin and per-
oxidase-labeled goat antirabbit lgG demonstrated that 
fibronectin within the central portion of the tumor lob-
ules was closely associated with the tumor cells. 
The absence of fibrinogen and factor VIII:Ag within 
the tumor tissue indicates that the fibronectin is proba-
bly not plasma- or s troma-derived while immunoperox-
idase data suggest that fibronectin may be a product of 
BCE cells. 
Fibronectin is a 440,000 da lton glycoprote in produced in 
cu lture by fibroblasts [1- 3], monocytes [ 4,5], a nd endothe lia l 
cells (6- 8] a nd/or de rived from se rum (9], t hat can bind to 
substratum and s im ulta neous ly to ce ll surfaces a nd, t he reby, 
promote attachmen t, spreading, a nd growth of t hese ce lls [10, 
11 ]. In vivo fibronectin is co ncen trated in areas of in te nse 
ce llular activity during embryogenesis [12, 13], delayed-type 
hypersens itivity [14], a nd wound repa ir (15- 19], suggesting t hat 
fib ro n ectin may provide a provis io na l substratum essen t ia l for 
cell migration and prolife ra t ion . M ost rece nt ly, C la rk et a l [18) 
have demonstrated t hat fibronect in occ urs under t he migrat ing 
epidermal tongue during reepi t h elia lization of an excis ion a l 
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wound and t hat a portion of the fibro nectin is produced in situ 
[20]. 
Basal cell ep it heliomas (BCE) a re com m on skin ca rc inomas 
t hat co n tain basem e n t m embra ne zone p roteins at t he pe riph-
e ry of t he t umor lobules [21- 25]. These prote ins include bullous 
pemphigoid a n t ige n [21,22 ), type IV collagen [22 ,23,25], typ e 
V co llagen [25 ], la minin (22- 25], a nd fibronectin [24]. Since 
fibronectin appea rs to be a n important if not esse n t ial prote in 
for t he migrating epidermal to ngue during reep it he li a lizatio n 
[20], it m ay be a n impo rta n t componen t in an invasive t um or 
suc h as t he BCE. The re fore, in t his investigat ion we addressed 
t h e nature o f fibron ectin distributio n in BCE and t he source o f 
t his glycoprote in. Direct immuno fluorescence was perfo rmed 
to de mo nstra te t he presen ce o r a bse nce a n d the distribu t ion of 
fibro nectin , fa ctor Vlii :Ag, a nd fibrin oge n in 6 BCEs. An 
indirect immunope rox idase technique fo r tlbronectin was e m -
ployed to furth er e lucidate t he distribution of this glycoprote in. 
MATERIALS AND METHODS 
BCE Tissue 
Tissue was obtained from 6 patients with biopsy-proved nodula r 
BCE, who were undergoing Moh's cont rolled excision . Excess tumor 
t issue was immediately placed in OCT compound and frozen in an 
Ames cryostat. 
Shin Immunofluorescence 
T he t issue specimens were cut in to 4-J.lm sections in an Ames cryostat 
and stored at -20'C. Fluorescein- labeled a nt ihuman factor Vlii :Ag 
was obtained from Atlant ic Antibodies, Scarborough, Maine, and fluo-
rescein -conjugated ant ihuman fibrin ogen was obtained from Cappel 
Laboratories, West Chester, Pennsylvania. Human fibronectin a nd 
ant isera to fibronectin were prepared and the latter examined for 
specificity as previously described [1 4,18- 20]. Antibodies were isolated 
by passage of the a ntisera over a P rotein A affini ty column 126], and 
t hen conjugated with rhoda mine by t he dia lys is method [27]. 
Four-micron sect ions taken from the BCE tissue were a ir dried, then 
washed in phosphate-buffered saline (PBS), pH 7.4 , 3 times fo r 15 min. 
For direct. immunofluorescence studies a 1:500 di lu t ion of the rhoda-
mine-conjugated ant ifibronectin antibodies was prepared in fi ltered 
PBS, pH 7.4 , and 1:250 dilut ions of t he fluorescein-conjugated anti -
factor VIII:Ag and anti fibrinogen antibodies were prepared in the same 
manner. The diluted ant ifibronectin conjugate was then mixed 1:1 
eit her with t he a nt i-facto r VI II:Ag conjugate or with the a ntifibrinogen 
conjugate. The tumor sections were placed in the incubation chambers 
for 2 h, washed in PBS 3 t imes, acetone fix ed, a nd then covered wi th 
a rece nt ly described mou nt ing medium 128] which facili tates t he eval-
uation of flu orescent specimens by decreasi ng flu orescein quenching 
a nd staining cells orange. T he specimens were viewed with a Zeiss epi -
illuminating microsope co nta ining an HB0-100 mercury light source 
and a fi lte r pack for flu orescein (BP 450-490, FT 510, LB 520) and 
rhodamine (BP 546/12, FT.580, LP590). 
I m.munoperoxidase T ech n.ique 
Four-micron sections taken from BCE t issue were ai r dried, t hen 
was hed in PBS, pH 7.4 , 3 t imes for 15 min. T he same a ntiserum to 
fibron ectin used in t he direct immunot1uorescence technique was used 
unconjugated (or the peroxidase technique. An avidin/biotin technique 
using a Vectastan ABC kit (Vector Laborato ries, Burlingame, Ca li for -
nia) was ut ilized for t he perox idase technique. Briefly, the 1:1000 
prima ry antibody solu t ion t.o fibron ecti n was incubated for 30 min with 
the 4-J.l.m sections, then washed for 10 min in PBS. Subsequently 
sections were incubated in the biotinylated a ffini ty-purified goat ant1-
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rabbit antise rum for 30 min. After washin g for 10 min in PBS, sections 
were incubated with the Avidin DH/biotinylated horseradish peroxi -
dase H co mplex supplied in t he Vectastan kit for 30 min. The sections 
were aga in washed for 10 min in buffer then incubated for 5 min in a 
peroxidase substrate solut ion. The peroxidase substrate was made by 
adding 5 drops of 0.3% H 20 2 to 10 ml of sodium acetate (0.1 M, pH 5.0) 
then adding 5 drops of 3 amino-9-ethylcarbazole (150 mg in I. cc of N-
N dimethylforma mide) and filtered. Afte r incubation in the peroxidase 
substrate, sections were washed in H20 for 10 min, air dried, and 
mounted in gelvato l. The specimens were viewed with a light micro-
scope. 
Light Microscopy 
A permanent 4-11 m section was made from eac h frozen tumor speci -
men using a polychrome stain containing to luidine blue and basic 
fuch sin . The t issue was fixed in 50% acetone, then placed in the sta in 
for 3 min . The specimen was then dipped 3 times in abso lu te alcohol 
then 3 t imes in xy lene with each specimen mounted with Histoclad 
a nd a cove rslip. 
RESULTS 
Light Microscopy of Frozen. BCE Specimens 
The light microscopic sections of frozen tissue stained with 
t he polyc hrome reagent gave good morphologic detail consist-
ent with nodular BCE in each case (Fig 1). 
Antifibron.ectin and An.tifibrin.ogen Double-Label Experiments 
Direct immunofluorence with rhodamine-conjugated anti-
human fibronectin demonstrated a broken linear or short fil a-
mentous pattern of positive sta ining at t he tumor margin and 
in the stroma between tumo r masses (Fig 2A ). Filamentous 
stai ning was a lso seen within the tumor mass itself (Fig 2A ). 
S ince t his specimen had been double labeled with fluorescein -
conjugated antifibrinogen as well as rhodamine-conjugated an -
tif'ibronectin, t he same field could be viewed under the immu-
nofluorescence microscope with fluorescein as well as rhoda-
mine filter packs (see Materials and Methods ). Since antifi-
brinogen antibodies cannot distinguish between fibrinogen and 
fibrin , in these experiments we assumed that all ti ssue deposits 
of fibrin ogen were in fact in t he form of fibrin. In all tumor 
sections double labe led wit h antibodies to fibronectin and fi -
brin , fibronectin was observed to be distributed within tumor 
masses as well as in the surrounding stroma, while fibrin was 
Pre 1. Representative tumor section demonstrating characteristic 
morphology of a nodular BCE using a polychrome sta in . Ori ginal 
magnification 40X. 
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noted on occasion in the stroma but never obse rved within the 
tumor substance (Fig 28 ). 
An.ti(ibronectin. and Anti-Factor VJJI:Ag Dou.ble-Label 
Experiments 
Again , direct immunofluorescence with rhodamine-conju-
gated antihuman fibronectin demonstrated a filamentous Pat-
tern of positive sta ining at t he margin of tumor lobu les and 
between lobules as well as focally within the tumor masses 
Frc 2. Direct immunofluorescence microscopy study of nodular 
BCE double labeled for fibronectin (rhodamine) and fibrin (fluores-
cein) . A, Positive rhodamine fluorescence for fibronectin is observed a 
a !ibrilla r pattern in t he stroma surrounding tumor lobu les (arrows ) 
and as short fibril s a nd punctae within t he tu mor substance itself 
(arrowheads ). 8 , Same field viewed with fluorescein fil ters. Positive 
!luorescence for fibrin is noted focally in one area of stroma surrounding 
BCE nodule (a rrow) but not within the tumor mass itself. The apparent 
background stainin g in tumor nodu les is secondary to orange cellular 
staining by para-phenylenediamine (see Materials and Methods). Orig-
inal magnifica t ion 200x . 
F eb. 1.984 
t he mse lves (Fig 3A ). When the same fie ld s hown in Fig 3A was 
v iewed with a fi lter pac k for flu orescein , sta ining for facto r 
VIII:Ag was noted only in blood vesse ls as a granular pattern 
(Fig 3B), co ns isten t wi t h previous results [28,29]. In a ll 6 
s pecimens, vessels, iden t ifia ble wit h an t i-facto r VIII:Ag, were 
n ever seen to course through tumor lobules. 
Antifibronectin I m.munopero:xidase Experiments 
Specimens sta ined for fibronectin wi th t he av idin/ biotin 
peroxidase-substrate sandwich demonstrated da rk deposits of 
peroxidase prod uct di scont inuous ly a long t he periph ery of tu-
mor masses in a fil a mentous patte rn (F1g 4A) consisten t w1 t h 
t hat visualized by immunofluorescence tec hnique with rhoda-
F I G 3. Direct immunonuoresence microscopy study of nodular BCE 
double labeled for fibron ectin (rhodamine) and factor VIII:Ag (fluores-
cein). A, Positive nuorescence for fibronectin is again seen as a fibrillar 
pattern in the stroma surrounding tumor lobules (arrows) and as 
punctae within the tumor substance itse lf (arrowheads). 8 , Same field 
viewed with Jluorescein filters. Positive lluorescence is apparent as 
punctae within blood vessel walls in the stroma surrounding tumor 
nodules (arrows). No staining is noted wi thin any tumor mass. Original 
magnification 200X. 
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FIG 4. Immunoperox idase study of nodular BCE using specific an-
tibod ies to human fibronectin. A, Positive sta ining for fibronectin is 
observed in a linea r pattern along much but not all of the tumor margin 
(arrow) and as punctae both in the stroma and within the tu mor mass 
(a rrowheads). Original magnification 200X. B, Higher magnification of 
the same spec imen . Positive fibri ll ar staining is noted at the tumor 
margin (arrow) and short fibrils and punctae are seen within the tumor 
mass (arrowheads). Original magnification 400x. 
mine-co njugated a n t ifibronectin. In addi t ion, t he tumor stroma 
conta ined dark depos its of perox idase product locali zed to blood 
vessels with weak but definite staining in t he in te rvascular 
pace (Fig 4A ). Wit hin t he tumor substance, fi bronectin was 
see n as s hort linea r deposits with the immunoperox idase tech -
nique (Fig 4A ) in exactly the same pattern and distribution as 
visua lized with t he immunoflu orescence technique (Figs 2A, 
3A ). In addi tio n, on high-power examination of the t issue, 
immunoperox idase deposits within the t umor substance seemed 
to be closely associated with individual tumor cells, often ap-
pearing as if t hey were coating part of t he cell surface membrane 
(Fig 4B). 
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DISCUSSIO N 
T his study has demonstrated t hat fibronectin in nodula r 
BCE is di stribu ted t hroughout t he tumor stroma, a round tumor 
lobules, a nd wit hin t he tumor substa nce itself. These resul ts 
co mpletely confi rm t he work of Ne lso n eta! [24) ; however , t he 
prev ious study did not in vestigate t he source(s) of fibronectin 
at t hese va rious s ites wi thin BCE t issue. 
F ibronectin at sites of inf1a mmation, wound repa ir, or tumor 
growth may be derived from e it her plasma or in situ production. 
Deposit ion of plasma fibronectin at sites o f infla mmation a nd 
wound healing usua lly if not always occurs in association wit h 
fib ri n. P rev ious work has shown t hat early in t he t ime course 
of wound healing, fibronectin be neath t he reepi t heli a li zing 
ep idermi s is plasma -derived and assoc iated wi t h fibrin [20) . 
Furthermore, in ea rlie r studi es, it has been demonstrated that 
p lasma-deri ved fibronectin is depos ited concomitan t ly wi t h 
fibrin in t he in te rstit ium of t he delayed-type hyperse nsitivity 
sk in reactions at 24 and 48 h a fte r ant ige n cha llen ge [1 4). 
T he refore, tne fact t hat fibronectin in t he t umor stroma is in 
part but not a lways associated wit h fibrin suggests t hat stroma 
fi bronecLi n is derived from both plasma a nd in situ production. 
In add it ion, t he lac k of any fibrin associat ion wi t h fibronectin 
in t he tumor substance suggests t hat t he fibronectin within t he 
tumor is not p lasma-deri ved. 
Since it is unlike ly t hat fi bronectin wit hin t he tumor sub-
stance is plasma-derived , sources o f in situ production must be 
co nside red. Connective t issue cells wi thin stroma ent rapped in 
t he t um or lobules could provide such a source . Both endothelia l 
cell s [6- 8] a nd fibroblasts [1- 3] are potent ia l sources of fibro-
nectin if t he in t ra lobula r fibron ectin is derived from ent rapped 
connective t issue cells. E ndothelia l cell s co nta ined wi thin BCE 
t umor su bstance s hould stain fo r facto r VIII:Ag [29,30]. Hence, 
t he lac k of facto r Vllf:Ag stain ing t he tumor lobules suggests 
t hat endotheli a l ce ll s a re not t he source of fi b ronectin and a lso 
suggests t hat extensive stromal en t rapment does not occur in 
BCE. In addi t ion, ut ili zi ng an a lka line phosphatase method for 
stainin g endothe lia l ce ll s, Wolff and H olubar [31] dem on -
strated t hat b lood vessels in vari able numbers course through 
st roma surroun ding BCE lobules bu t not through the lobules 
themselves. Furt hermore, in ul tast ructura l studies of BCE , 
neit he r capilla ries nor fibroblasts were observed in the t umor 
masses o f nodul a r BCE [32,33]. T hus, our own and previous 
observations are aga inst t he prese nce of eit her endothelia l cell s 
or fi brob lasts in lobules of nodula r BCE as potent ia l sources of 
in t ra lobul a r fibronectin . 
Wi t h imm unoperox idase li ght microscopic studies, ti bronec-
t in appea red to be directly associated wi t h tumor ce ll s. Aga in, 
we saw no ev idence of stroma ent rapment wi t hin t he fibronec-
t in co nta ining tumor lobules . T hese findin gs correspond to 
e lectron microscop ic obse rvations t ha t t he extracella r spaces 
t hat sometimes develop betwee n basaloid cells of nodula r BCE 
conta in a fibrill a r mate ri a l close ly associated wit h t he baseloid 
ce ll s bu t co ntain neit her elastic nor co ll age n fiber s [32,33]. If 
ne it he r plas ma, endotheli a l ce ll s, nor fibroblasts a re potent ia l 
sources of t he fibronectin wi t hin t he tum or substance, t hen 
pe rh aps basa l epit heli oma cells t hemse lves produce and deposit 
fi b ronectin. 
T he poss ib ili ty t hat BCE ce ll s may syn t hesize, secrete, a nd 
depos it fihronecti n in a pe rice llula r matrix is given rea l cre-
dence by a rece nt study in whi ch Kubo et a l have demonstrated 
t hat huma n ke rat inocytes in cul t ure p roduce fibron eclin [34). 
T hi s study examined nonstrati fi ed huma n ke rat inocyte cul-
tures in a low-calcium, se rum -free medium , wi t hout a fib roblas t 
feeder layer or other adherence matri x. Wi t h F (ab ') 2 an t ihu -
ma n fi bronectin a nd F ITC-co njugated goat an t irabbit IgG 
sta in in g, a granular cytoplas mic flu orescen ce wi t h perinuclea r 
acce n tuation was see n in a ll o f t he cul t u red ke ratinocytes. 
E nzyme immunoassay co nfirmed t hat t he serum -free medium 
co nta ined no detectable fibronectin but fibronectin was presen t 
in t he medium afte r 4 days of cul ture. lmmunoe lectron mic ros-
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copy revea led fibronectin in ep ide rma l cells loca lized to t h e 
pen nuclear region assoc iated with eit her the endop las mic retic -
ulum or Go lgi system and nuclea r membra ne. The conclus io n 
of t he study was t hat epide rmal keratinocytes in certa in phe n -
otypiC states can produce and sec ret e fibronectin. 
Alt hough fibronectin is not norm ally found in t he intact 
adul t human epidermi s, including t he basa l ce ll laye r , fibro nec-
t in production a nd sec retion may be appa ren t in ce rta in states 
of keratmocyte p henotypic exp ress ion as seen in low-ca lc iu m 
cul t ure co ndi t ions, at t he t ip of the migrat ing epidermi s durin cr 
wound repa ir, a nd in BCE. "' 
In summary, we have demonstrated t he distribution of fib ro-
nectininBCE to be in t he stroma surroundin g tumor lobules 
and withm t he tum or substance close ly assoc iated wit h t h e 
basaloid cells. The source of stromal fibronectin probably d e-
n ves from both plasma and in sit u p roduction of fibroblasts 
and/o r endothelia l ce lls [35). In co nt rast, fi bronectin wi t hin 
the t umor substance probably derives from in situ production 
by basaloid cells, a lt hough addit iona l studies are needed fo r 
definitive proof t hat BCE cell s produce and sec rete fi b ronectin . 
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